We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.125 | -2.67% | 4.55 | 4.11 | 4.99 | 4.41 | 4.35 | 4.39 | 482,311 | 16:35:06 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 29/10/2020 11:04 | I take it the consensus is that the 'offer' was under subscribed then. Odd when the much larger placing was over subscribed. This doesn't make sense to me. I've been in this game long enough to know that the market is easily manipulated but will have to wait until the offer allocations are announced next week before things become clear. Whatever happens the company should have enough cash bring their products to market, even if the Covid product doesn't get approval or is too late because of some miracle vaccine, there are other promising products. Main risk is that SNG is taken over for a song just when the investment is about to take off. | slogsweep | |
| 29/10/2020 11:04 | I wonder to what extent the open offer was taken up? With the share price in the doldrums, I'd be surprised if it was oversubscribed. | investordave |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
